A closer look at the tools in Galil’s new software environment GDK

The Galil Design Kit (GDK) is Galil’s newest software environment that provides easy communication with Galil’s motion controllers and PLCs. Galil has recently introduced the new Scope and Tuner to GDK’s growing list of tools and capabilities. All tools are customizable by editing the XLM that’s located in the “More Options” menu at the top right corner of the GDK software.

GDK now includes the following six tools:

  • Scope:  emulates a traditional digital Oscilloscope.
  • Tuner:  assists the user in optimizing their system’s performance.
  • Terminal: send commands and receive responses from the controller.
  • Editor: write, save, and execute application programs.
  • Viewer: enables real-time viewing of the controller’s I/O status, motor position, and more.
  • Setup: read, edit, save, and restore all controller memory.

Read more

We welcome Michael Ullskog as our new CEO

After 16 years as CEO of Compotech Jan Eriksson has decided to hand over the reins to Michael Ullskog, recruited from the same position at our sister company RECAB. Read more

Compotech expands to the Benelux!

The Compotech Benelux sales office is strategic located in The Hague. Read more

Gyrolab xPlore

A Swedish contribution to a healthier world

Biopharmaceuticals are the future of the pharmaceutical industry. Groundbreaking progress is made every year, and pharmaceuticals tailored for our individual genetic conditions are believed not to be too farfetched.

xplore-400-365x312

Photo: Gyros Protein Technologies AB

In the middle of this revolution is the Swedish company Gyros AB, based in Uppsala. Practically every large pharmaceutical that develops and manufactures biopharmaceuticals is already using their so-called immunoassay platform, a system that analyses samples in pre-clinical and clinical trials. And with the introduction of the Gyrolab xPlore, the company has presented a product that lowers the threshold for even more labs around the globe to start using their revolutionary platform in the pursuit of alleviate and cure disease. Read more